Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 5, 2013, Pages 444-448

  Ha, Young Eun ^a   Kang, Cheol In ^a   Wi, Yu Mi ^b   Chung, Doo Ryeon ^a   Kang, Eun Suk ^c   Lee, Nam Yong ^c   Song, Jae Hoon ^a   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Bacteremia; C reactive protein; Procalcitonin; Pyelonephritis; Sensitivity and specificity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

ACUTE PYELONEPHRITIS; ADULT; AGE; AGED; ARTICLE; BACTEREMIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMERGENCY WARD; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOTENSION; KLEBSIELLA INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS INFECTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84882445549     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.803231     Document Type: Article

References (24)

1. BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med 1997; 15 : 137-40.
2. Wing DA, Park AS, Debuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol 2000; 182 : 1437-40.
3. Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006; 332 : 175-80.
4. Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, Quinquis L, Schmidt J, Kierzek G, Guerin S, Hausfater P, Bernot B, Brun P, Gayet A, Casalino E, Andreotti C, Renaud B, Claessens YE. Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis Biomarkers 2011; 16 : 355-63.
5. van Nieuwkoop C, Bonten TN, Van 't Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, van Dissel JT. Procalcitonin refl ects bacteremia and bacterial load in urosepsis syndrome: aprospective observational study. Crit Care 2010; 14 : R206.
6. Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, Kierzek G, Guerin S, Pourriat JL, Dhainaut JF, Ginsburg C. Can C-reactive protein, procalcitonin and midregional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2010; 16 : 753-60.
7. Lemiale V, Renaud B, Moutereau S, N'G ako A, Salloum M, Calmettes MJ, Herve J, Boraud C, Santin A, Grego JC, Braconnier F, Roupie E. Asingle procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007; 51 : 1394-401.
8. Limper M, De Kruif MD, Ajubi NE, Van Zanten AP, Brandjes DP, Duits AJ, van Gorp EC. Procalcitonin as apotent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department. Eur J Clin Microbiol Infect Dis 2011; 30 : 831-6.
9. Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, Chen HY, Chiu TF. Procalcitonin as abiomarker for bacteriaLinfections in patients with liver cirrhosis in the emergency department. AcaDemerg Med 2011; 18 : 121-6.
10. Caterino JM, Scheatzle MD, Forbes ML, D'A ntonio JA. Bacteremic elder emergency department patients: procalcitonin and white count. AcaDemerg Med 2004; 11 : 393-6.
11. Kim MH, Lim G, Kang SY, Lee WI, Suh JT, Lee HJ. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J2011; 52 : 276-81.
12. Hantz S, Garnier-Geoffroy F, Mazeron M-C, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle J-P, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S, French CMVRSSG. Drug-resistant cytomegalovirus in transplant recipients: aFrench cohort study. J Antimicrob Chemother 2010; 65 : 2628-40.
13. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15(Suppl. 1) : S216-27.
14. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: areason to change the accepted defi nition of community-acquired infections. Ann Intern Med 2002; 137 : 791-7.
15. da Cunha-Bang C, Iversen M, Mortensen SA, Rasmussen A, Sengelov H, Sorensen SS, Lundgren J. Regarding: Humar. The effi cacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 2010; 10 : 1228-1237. Am J Transplantat 2011;11:408.
16. Bossuyt PM, Reitsma JB, Bruns De, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326 : 41-4.
17. Simel DL, Rennie D, Bossuyt PM. The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J Gen Intern Med 2008; 23 : 768-74.
18. Perkins NJ, Schisterman EF. The inconsistency of " optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006; 163 : 670-5.
19. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329 : 168-9.
20. Velasco M, Martinez JA, Moreno-Martinez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary Clin Infect Dis 2003; 37 : 1127-30.
21. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in communityacquired pneumonia. Am JMed 2008; 121 : 219-25.
22. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as amarker of ventilator-associated pneumonia resolution: apilot study. Eur Respir J2005; 25 : 804-12.
23. Verhagen DW, Hermanides J, Korevaar JC, Bossuyt PM, van den Brink RB, Speelman P, van der Meer JT. Prognostic value of serial C-reactive protein measurements in leftsided native valve endocarditis. Arch Intern Med 2008; 168 : 302-7.
24. Ha YE, Kang CI, Joo EJ, Joung MK, Chung DR, Peck KR, Lee NY, Song JH. Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia. Korean JIntern Med 2011; 26 : 195-200.